Molecular recognition in vitamin D-binding protein

Proceedings of the Society for Experimental Biology and Medicine

Volumn 212, Issue 4, 1996, Pages 305-312

  Ray, Rahul ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CALCIFEDIOL; COLECALCIFEROL DERIVATIVE; FATTY ACID; MACROPHAGE ACTIVATING FACTOR; MUTANT PROTEIN; STEROL; VITAMIN D BINDING PROTEIN; VITAMIN RECEPTOR;

LIGAND BINDING; MOLECULAR RECOGNITION; PROTEIN DOMAIN; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

EID: 0029799260     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-212-44020     Document Type: Short Survey

References (55)

1. Holick MF. Vitamin D - New horizons for the 21st century. Am J Clin Nutr 60:619-630, 1994.
2. DeLuca HF. The vitamin D story: A collaborative effort of basic science and clinical medicine. Fed Proc Am Soc Exp Biol 2:224-236, 1988.
3. Cooke NE, Haddad JG. Vitamin D binding protein (Gc-globulin). Endocr Rev 10:294-307, 1989.
4. Yang F, Brune JI, Naylor SL, Cupples RL, Naberhaus KH, Bowman BH. Human group-specific component (Gc) is a member of the albumin family. Proc Natl Acad Sci USA 82:7994-7998, 1985.
5. Cooke NE, David EV. Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J Clin Invest 76:2420-2424, 1985.
6. 3 receptors: Structure and function in transcription. Annu Rev Nutr 11:189-216, 1991.
7. Swamy N, Roy A, Chang R, Brisson M, Ray R. Affinity purification of human plasma vitamin D-binding protein. Protein Expr Purif 6:185-188, 1995.
8. Haddad JG. Transport of vitamin D metabolites. Clin Orthop Relat Res 142:249, 1979.
9. Bouillon R, Van Baelen H. The transport of vitamin D: Significance of free and total concentrations of vitamin D metabolites. In: Norman AW, Schaefer K, Herrath DV, Grigoleit HG, Eds. Vitamin D, Chemical Biochemical and Clinical Endocrinology of Calcium Metabolism. New York: Walter de Gruyter, pp1181-1186, 1982.
10. Van Baelen H, Bouillon R, DeMoor P. Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem 255:2270-2272, 1980.
11. Haddad JG. Human serum binding protein for vitamin D and its metabolites (DBP): Evidence that actin is the DBP binding component in human skeletal muscle. Arch Biochem Biophys 213:538-544, 1982.
12. Williams MH, Van Alstyne EL, Galbraith RM. Evidence of a novel association of unsaturated fatty acids with Gc (vitamin D-binding) protein. Biochem Biophys Res Commun 153:1019-1024, 1988.
13. Ena JM, Esteben C, Perez MD, Uriel J, Calvo M. Fatty acids bound to vitamin D-binding protein (DBP) from human and bovine sera. Biochem Int 19:1-7, 1989.
14. Calvo M, Ena JM. Relations between vitamin D and fatty acid binding properties of vitamin D-binding protein. Biochem Biophys Res Commun 163:14-17, 1989.
15. Bouillon R, Xiang R, Convents R, Van Baelen H. Polyunsaturated fatty acids decrease the apparent affinity of vitamin D metabolites for human vitamin D-binding protein. J Steroid Biochem Mol Biol 42:855-861, 1992.
16. Kew RR, Webster RO. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. J Clin Invest 82:364, 1988.
17. Petrini MD, Emerson DL, Galbraith RM. Linkage between surface immunoglobulin and cytoskeleton of B lymphocytes may involve Gc protein. Nature 306:73-74, 1983.
18. Petrini M, Galbraith RM, Emerson DL, Nel AE, Arnaud P. Structural studies of T-lymphocyte Fc receptors. J Biol Chem 260:1804-1810, 1985.
19. Nester JE, McLeod JF, Kowalski MA, Strauss IF III, Haddad JG. Detection of vitamin D binding protein on the surface of cytotrophoblasts isolated from human placentae. Endocrinology 120:1996, 1987.
20. Schoentgen F, Metz-Boutigue M, Jolles J, Constans J, Jolles P. Complete amino acid sequence of human vitamin D-binding protein (group specific component): Evidence of a three-fold internal homology as in serum albumin and α-fetoprotein. Biochem Biophys Acta 871:189-198, 1986.
21. Sweet FW, Murdock GL. Affinity labelling of hormone specific proteins. Endocr Rev 8:154-184, 1987.
22. Haddad JG, Hu YZ, Kowalski MA, Laramore C, Ray K, Robzyk P, Cooke NE. Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (Gc-globulin). Biochemistry 31:7174-7181, 1992.
23. 3-3β-(1,2-epoxypropyl)ether: An affinity labeling reagent for human vitamin D-binding protein. Arch Biochem Biophys 319:504-507, 1995.
24. 3. Biochemistry 26:3957-3964, 1987.
25. 3-3-[N-(4-azido-2-nitrophenyl)glycinate]. Biochemistry 25:4729-4733, 1986.
26. 3. Biochemistry 36:4809-4813, 1991.
27. 3-binding site. Biochemistry 30:7638-7642, 1991.
28. 3), its biological precursors, and other steroidal alcohols: An anchoring moiety for affinity studies of sterols. Steroids 60:530-533, 1995.
29. Swamy N, Ray R. Binding site mapping of vitamin D binding protein. Report presented at the Ninth Workshop on Vitamin D, Orlando, FL, 1994.
30. 3 to human serum vitamin D-binding protein. J Biol Chem 270:2636-2639, 1995.
31. Lind SE, Smith DB, Janmey PA, Stossel TP. Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J Clin Invest 78:736-742, 1986.
32. Goldschmidt-Clermont PJ, Williams MH, Galbraith RM. Altered conformation of Gc (vitamin D-binding protein) upon complexing with cellular actin. Biochem Biophys Res Commun 146:611-617, 1987.
33. Goldschmidt-Clermont PJ, Allen RC, Nel AE, Emerson DL, Day JR, Galbraith RM. Gc (vitamin D-binding protein) binds the 33.5 K tryptic fragment of actin. Life Sci 38:735-742, 1986.
34. Houmeida A, Hanin V, Constans J, Benyamin Y, Roustan C. Localization of vitamin D-binding protein interaction site in the COOH-terminal sequence of actin. Eur J Biochem 203:499-503, 1992.
35. Spector AA. Plasma albumin as a lipoprotein. In: Scanu AM, Spector AA, Eds. Biochemistry and Biology of Plasma Lipoproteins. New York: Marcel Dekker, pp247-279, 1986.
36. Reed RG. Location of long chain fatty acid-binding sites of bovine serum albumin by affinity labeling. J Biol Chem 261:15619-15624, 1986.
37. Swamy N, Ray R. High-level bacterial expression and purification of vitamin D-binding protein and vitamin D receptor. Abstract presented at the Seventeenth Annual Meeting of the American Society for Bone and Mineral Research, Baltimore, MD, 1995.
38. Yamamoto N, Homma S, Millman I. Identification of the serum factor required for in vitro activation of macrophages. J Immunol 147:273-280, 1991.
39. 3 binding protein (group specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci USA 88:8539-8543, 1991.
40. Yamamoto N, Lindsay DD, Naraparaju VR, Ireland RA, Popoff SN. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats. J Immunol 152:5100-5107, 1994.
41. Schneider GB, Popoff SN. Vitamin D binding protein-macrophage activating factor and bone: Beneficial effects of DBP-MAF infusion on skeletal functions in osteopetrotic rats. In: Norman AW, Bouillon R, Thomasset M, Eds. Vitamin D, A Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications. New York: Walter de Gruyter, pp718-719, 1994.
42. Popoff SN, Schneider GB. Conversion of the vitamin D binding protein to a macrophage activating factor: Associated defects in osteopetrotic mutations. In: Norman AW, Bouillon R, Thomasset M, Eds. Vitamin D, A Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications. New York: Walter de Gruyter, pp693-701, 1994.
43. Schneider GB, Benis KA, Flay NW, Ireland RA, Popoff SN. Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone 16:657-662, 1995.
44. Viau M, Constans J, Debray H, Montreuil J. Isolation and characterization of the O-glycan chain of the human vitamin D binding protein. Biochem Biophys Res Commun 117:324, 1983.
45. 3. J Chem Soc Chem Comm 11:702-703, 1985.
46. 3 receptor. Biochem Biophys Res Commun 132:198-203, 1985.
47. 3. Steroids 51:623-630, 1988.
48. 3 receptor. Steroids 58:462-465, 1993.
49. 3 receptor. Biochim Biophys Acta 1073: 324-328, 1991.
50. 3. Bioorganic Chem 22:276-283, 1994.
51. 3 receptor. J Biol Chem 271:2012-2017, 1996.
52. Eales LJ, Nye KE, Parkin JM, Weber JN, Forster SM, Harris JRW, Pinching AJ. Association of different allelic forms of group specific component with susceptibility to and clinical manifestation of human immunodeficiency virus infection, (letter) Lancet 1:1378, 1987.
53. Daiger SP, Brewton GW, Rios AA, Mansell PWA, Reuben JM. Genetic susceptibility to AIDS: Absence of an association with group specific component (Gc). (letter) N Engl J Med 317:631-632, 1987.
54. Constans J, Smilovici W, Ducos J, Robert J, Boneu B. Group specific component and HIV infection. (letter) Lancet 2:40, 1987.
55. Gilles K, Louie L, Newman B, Crandall J, King MC. Genetic susceptibility to AIDS: Absence of an association with group specific component (Gc). N Engl J Med 317:630-631, 1987.